Hjem › Ikke-småcellet lungekreft › Illinois › Cicero
Kliniske studier for Ikke-småcellet lungekreft i Cicero, IL
24 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Cicero (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
RekruttererFase 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · 10 mi unna
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- Edward Hines Jr VA Hospital, Hines · 4 mi unna
- Advocate Christ Medical Center, Oak Lawn · 9 mi unna
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruttererFase 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi unna
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruttererFase 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi unna
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekruttererFase 3
- Advocate Christ Medical Center, Oak Lawn · 9 mi unna
- Hope and Healing Cancer Services, Hinsdale · 10 mi unna
- Endeavor Health, Elmhurst · 10 mi unna
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
RekruttererFase 2
- Hope and Healing Clinical Research, Hinsdale · 10 mi unna
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
RekruttererFase 3
- Research Site, Hinsdale · 10 mi unna
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
RekruttererFase 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi unna
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
RekruttererFase 3
- Research Site, Hinsdale · 10 mi unna
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekruttererFase 2/3
- Loyola University Medical Center, Maywood · 5 mi unna
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
RekruttererFase 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi unna
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekruttererFase 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi unna
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RekruttererFase 3
- Research Site, Hinsdale · 10 mi unna
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RekruttererFase 3
- Research Site, Hinsdale · 10 mi unna
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
RekruttererFase 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi unna
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RekruttererFase 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · 10 mi unna
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruttererFase 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi unna
- Edward Hines Jr VA Hospital, Hines · 4 mi unna
- Loyola University Medical Center, Maywood · 5 mi unna
- og 2 flere
MYLUNG Consortium Part 3: Observational Study
RekruttererObservasjonsstudie
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi unna
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2
- Edward Hines Jr VA Hospital, Hines · 4 mi unna
- Loyola University Medical Center, Maywood · 5 mi unna
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi unna
- og 3 flere
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2/3
- Loyola University Medical Center, Maywood · 5 mi unna
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi unna
- Advocate Christ Medical Center, Oak Lawn · 9 mi unna
- og 2 flere
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2
- Edward Hines Jr VA Hospital, Hines · 4 mi unna
- Loyola University Medical Center, Maywood · 5 mi unna
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi unna
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruttererObservasjonsstudie
- Advocate Christ Medical Center, Oak Lawn · 9 mi unna
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi unna
- Advocate High Tech Medical Park, Palos Heights · 12 mi unna
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Rekrutterer
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 mi unna
GEMINI-NSCLC: NSCLC Biomarker Study
RekruttererObservasjonsstudie
- Hope and Healing Cancer Services, Hinsdale · 10 mi unna
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Cicero
- Lungekreft17 studier
- Prostatakreft14 studier
- Kreft (alle typer)13 studier
- Brystkreft11 studier
- Akut myelogen leukemi11 studier
- Kolorektal kreft10 studier
- Blærekreft8 studier
- Melanom7 studier
- Kardiovaskulær sykdom7 studier
- Metastatisk kreft7 studier
- Multipelt myelom6 studier
- Burkitts lymfom6 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.